• Every dose printed on the panel
  • Prices shown per serving
  • Cautions printed on the page
  • 30-day money-back guarantee
Which routine is right for you?See your routine

Research review

Can digestive enzymes lower cholesterol? What the research does and doesn't show

No trial we've found tests a digestive enzyme supplement, including DigeZyme, for an effect on cholesterol. The nearest research measured cholesterol as one marker in a completely different, diagnosed pancreatic disease, and found no significant association.

By Electric Tiger Editorial

No trial we've found tests a digestive enzyme supplement, including DigeZyme, for an effect on cholesterol. The closest research checked cholesterol as one of several blood markers in a completely different, diagnosed pancreatic disease — and cholesterol didn't come back as one of the markers linked to enzyme deficiency there either.

What the evidence doesn't support

It doesn't support digestive enzyme supplements as a way to lower cholesterol, or as having any measured effect on a cholesterol reading at all, in either direction. No controlled trial we've found has tested a digestive-enzyme product's effect on total cholesterol, LDL, HDL or triglycerides.

What the trials found

The only controlled trial of DigeZyme itself gave 40 adults with functional dyspepsia the enzyme blend alone — 150 mg a day for 60 days — against a placebo, and reported improved symptom scores with no product-related adverse events; it did not measure cholesterol at all.

A 2012 study in 114 people with chronic pancreatitis is the nearest thing to relevant cholesterol data we found, and it's a marker study, not a supplement trial. Researchers compared a panel of blood values, cholesterol and triglycerides among them, between the 38 patients who had confirmed pancreatic exocrine insufficiency (a diagnosed condition where the pancreas stops making enough of its own digestive enzymes) and those who didn't. Low magnesium, low hemoglobin, low albumin, low prealbumin, low retinol-binding protein and elevated HbA1c were significantly linked to the insufficiency; cholesterol and triglycerides were measured but not among the markers that came back significant. In other words, in the one population where enzyme deficiency is an actual diagnosed disease, cholesterol wasn't a marker that tracked with it.

Prescription-strength pancreatic enzyme replacement therapy is prescribed for that diagnosed insufficiency — helping the body absorb fat and other nutrients it otherwise can't — not to change a cholesterol number in someone without the condition. It's also a different, higher-dose product than an over-the-counter blend like DigeZyme, so even where enzyme replacement therapy has been studied for other outcomes, those results don't transfer to a consumer supplement.

Questions people ask

Can digestive enzymes lower cholesterol?

No trial we've found has tested this. The nearest available research measured cholesterol as one marker among many in a diagnosed pancreatic disease and found no significant link to enzyme deficiency, which doesn't support an effect on cholesterol in either direction.

Does DigeZyme affect cholesterol?

The one controlled trial of DigeZyme, in adults with functional dyspepsia, didn't measure cholesterol as an outcome, so there's no direct evidence about this specific blend and cholesterol either way.

When to talk to a doctor

High cholesterol is diagnosed and managed by a doctor, usually with diet, lifestyle changes and, where indicated, medication. Digestive enzyme supplements are not a treatment for high cholesterol, and nothing in the research above supports using one for that purpose. If you take medication for cholesterol or a related condition, ask a doctor before adding any supplement.

See what is DigeZyme and digestive enzymes: what the research does and doesn't show for the wider evidence on this ingredient.

Sources

  1. Evaluation of the Safety and Efficacy of a Multienzyme Complex in Patients with Functional Dyspepsia: A Randomized, Double-Blind, Placebo-Controlled Study Journal of medicinal food · 2018 · PMID 30156436A 2018 placebo-controlled trial found that adults with functional dyspepsia who took DigeZyme (150 mg/day) for 60 days scored significantly better on several symptom questionnaires than those given a placebo, with no reported product-related side effects; the trial was run and funded by DigeZyme's own maker.
  2. Serum nutritional markers for prediction of pancreatic exocrine insufficiency in chronic pancreatitis Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] · 2012 · PMID 22898630A 2012 study of 114 people with chronic pancreatitis measured cholesterol alongside other blood markers to see which ones tracked with pancreatic exocrine insufficiency (a diagnosed enzyme-deficiency disease); several markers were significantly linked to it, but cholesterol was not one of them.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.